Publications

Showing entries 21 - 40 out of 101

2021


2020


Meier-Menches SM, Neuditschko B, Zappe K, Schaier M, Gerner MC, Schmetterer KG et al. An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells. Chemistry: A European Journal. 2020 Dec 1;26(67):15528-15537. doi: 10.1002/chem.202003495

Wernitznig D, Meier-Menches SM, Cseh K, Theiner S, Wenisch D, Schweikert A et al. Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics. 2020 Dec 1;12(12):2121-2133. doi: 10.1039/d0mt00227e

Losytskyy M, Chornenka N, Vakarov S, Meier-Menches SM, Gerner C, Potocki S et al. Sensing of Proteins by ICD Response of Iron(II) Clathrochelates Functionalized by Carboxyalkylsulfide Groups. Biomolecules. 2020 Dec;10(12):1-16. 1602. doi: 10.3390/biom10121602

Baier DS, Schönhacker-Alte B, Pirker C, Englinger B, Mohr T, Meier-Menches S et al. Lipid metabolism as target and modulator of KP1339 anticancer activity. Cancer Research. 2020 Aug;80(16):Meeting Abstract: 1839 . doi: 10.1158/1538-7445.AM2020-1839

Thomas SR, Bonsignore R, Sanchez Escudero J, Meier-Menches SM, Brown CM, Wolf MO et al. Exploring the Chemoselectivity towards Cysteine Arylation by Cyclometallated Au(III)Compounds: New Mechanistic Insights. ChemBioChem: a european journal of chemical biology. 2020 Jul 8;21(21):3071-3076. doi: 10.1002/cbic.202000262

Meier-Menches SM, Casini A. Design Strategies and Medicinal Applications of Metal-Peptidic Bioconjugates. Bioconjugate Chemistry. 2020 May 20;31(5):1279-1288. doi: 10.1021/acs.bioconjchem.0c00152

Mokesch S, Cseh K, Geisler H, Hejl M, Klose MHM, Roller A et al. Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles. Frontiers in Chemistry. 2020 Apr 3;8:209. doi: 10.3389/fchem.2020.00209

Englinger B, Laemmerer A, Moser P, Kallus S, Roehrl C, Pirker C et al. Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib. International Journal of Cancer. 2020 Mar 2;147(6):1680-1693. doi: 10.1002/ijc.32924

2019


Kreutz D, Gerner C, Meier-Menches SM. Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents. In Casini A, Vessieres A, Meier-Menches SM, editors, Metal-based Anticancer Agents . Royal Society of Chemistry. 2019. p. 246-270. (RSC Metallobiology; No. 14, Vol. 2019-January). doi: 10.1039/9781788016452-00246

van Dijk F, Teekamp N, Post E, Schuppan D, Kim YO, Zuidema J et al. The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor. Journal of Controlled Release. 2019 Feb 28;296:250-257. doi: 10.1016/j.jconrel.2018.12.039

2018


Carboni S, Zucca A, Stoccoro S, Maiore L, Arca M, Ortu F et al. New Variations on the Theme of Gold(III) C N N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization. Inorganic Chemistry. 2018 Dec 3;57(23):14852-14865. doi: 10.1021/acs.inorgchem.8b02604

Klose MHM, Theiner S, Varbanov HP, Hoefer D, Pichler V, Galanski MS et al. Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes. In Contel M, editor, Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile. 4 ed. Vol. 6. Basel: Multi-disciplinary digital publishing institute (MDPI). 2018. p. 71-84. 130. (Inorganics). doi: 10.3390/inorganics6040130

Klose MHM, Schöberl A, Heffeter P, Berger W, Hartinger CG, Koellensperger G et al. Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC-ICP-MS. Monatshefte für Chemie. 2018 Oct;149(10):1719-1726. doi: 10.1007/s00706-018-2280-1

Muqaku B, Eisinger M, Meier-Menches SM, Tahir A, Pukrop T, Haferkamp S et al. Reprogramming of organ functions via systemic calcium mobilization. In Book of Abstracts. 2018

Babak MV, Pfaffeneder-Kmen M, Meier-Menches SM, Legina MS, Theiner S, Licona C et al. Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action. Inorganic Chemistry. 2018 Mar 5;57(5):2851-2864. doi: 10.1021/acs.inorgchem.7b03210

Klose MHM, Theiner S, Kornauth C, Meier-Menches SM, Heffeter P, Berger W et al. Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS. Metallomics: integrated biometal science. 2018 Mar 1;10(3):388-396. doi: 10.1039/c8mt00012c

Showing entries 21 - 40 out of 101